MarketCap
Facebook
X
TelegramQuarterly report 2024-Q4
added 05-06-2026
Trinity Biotech plc Shares 2011-2026 | TRIB
Annual Shares Trinity Biotech plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 359 M | 153 M | 135 M | 83.6 M | 20.9 M | 83.6 M | 83.6 M | 86.5 M | 91.9 M | 110 M | 94.9 M | 93.7 M | 89.8 M | 88.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 359 M | 20.9 M | 112 M |
Quarterly Shares Trinity Biotech plc
| 2024-Q4 | 2024-Q2 | 2023-Q4 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 359 M | 183 M | 153 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 26.2 M | - | - | - | 27.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 359 M | 26.2 M | 150 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 204.2 | -0.16 % | $ 22.7 B | USA |
 |
Celcuity
CELC
|
46.8 M | $ 88.61 | -4.3 % | $ 4.14 B | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
30.8 M | $ 19.01 | 2.76 % | $ 585 M | USA |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 4.24 | -5.89 % | $ 5.64 M | USA |
 |
Castle Biosciences
CSTL
|
29 M | $ 21.24 | 0.74 % | $ 616 M | USA |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
23.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
125 M | $ 131.17 | 0.81 % | $ 16.4 B | USA |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 23.6 | 3.74 % | $ 1.26 B | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
78.4 M | $ 147.79 | -2.65 % | $ 11.6 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
6.23 M | - | - | $ 9.42 M |  Israel |
 |
Illumina
ILMN
|
155 M | $ 165.27 | 3.27 % | $ 25.6 B | USA |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 1.76 | 1.32 % | $ 7.79 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
132 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
464 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 102.21 | 2.23 % | $ 6.9 B | USA |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 188.58 | -0.67 % | $ 9.35 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 471.62 | 1.03 % | $ 13.6 B | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
20.6 M | $ 1 133.54 | -2.53 % | $ 23.4 B |  Schweiz |
 |
NeoGenomics
NEO
|
128 M | $ 11.54 | 0.87 % | $ 1.48 B | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 4.6 | 1.32 % | $ 426 M | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 21.06 | 6.63 % | $ 471 M | USA |
 |
Natera
NTRA
|
137 M | $ 217.0 | -2.61 % | $ 29.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
300 M | $ 1.4 | 2.19 % | $ 420 M | USA |
 |
Personalis
PSNL
|
89.2 M | $ 9.81 | 0.62 % | $ 875 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
948 M | $ 25.8 | -2.66 % | $ 24.5 B |  Niderland |
 |
Senseonics Holdings
SENS
|
41.7 M | $ 7.24 | -2.56 % | $ 302 M | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
50.8 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
2.3 M | $ 2.05 | -0.29 % | $ 4.71 M | USA |
 |
Twist Bioscience Corporation
TWST
|
59.8 M | $ 68.85 | -1.73 % | $ 4.12 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 269.13 | -0.76 % | $ 22.4 B | USA |
 |
Thermo Fisher Scientific
TMO
|
377 M | $ 484.66 | -1.9 % | $ 183 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
217 M | $ 9.2 | -1.02 % | $ 2 B | USA |
 |
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | USA |